Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Human IGFBP-rp1/IGFBP-7 DuoSet ELISA, 5 Plate
angiomodulin
FSTL2
IBP-7
IGFBP7
IGFBP-7
IGFBP-7PGI2-stimulating factor
IGFBP-7v
IGFBPrp1
IGFBP-rp1
insulin-like growth factor binding protein 7
insulin-like growth factor-binding protein 7
MAC25 protein
Mac25
MAC25IGF-binding protein 7
Prostacyclin-stimulating factor
PSF
PSFAGM
TAF
Tumor-derived adhesion factor
Background
The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and at least four additional low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-translational modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. ALS (Acid Labile Subunit) is a liver-derived protein that exists in a ternary complex with Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) or IGFBP-5, and either IGF-I or IGF-II. ALS increases the half-life of IGF/IGFBP complexes in circulation.